Cost-related medication non-adherence among U.S. adults with diabetes
- PMID: 29944967
- PMCID: PMC6204232
- DOI: 10.1016/j.diabres.2018.06.016
Cost-related medication non-adherence among U.S. adults with diabetes
Abstract
Aims: To examine factors that affect cost-related medication non-adherence (CRN), defined as taking medication less than as prescribed because of cost, among adults with diabetes and to determine their relative contribution in explaining CRN.
Methods: Behavioral Risk Factor Surveillance System data for 2013-2014 were used to identify individuals with diabetes and their CRN. We modeled CRN as a function of financial factors, regimen complexity, and other contextual factors including diabetes care, lifestyle, and health factors. Dominance analysis was performed to rank these factors by relative importance.
Results: CRN among U.S. adults with diabetes was 16.5%. Respondents with annual income <$50,000 and without health insurance were more likely to report CRN, compared to those with income ≥$50,000 and those with insurance, respectively. Insulin users had 1.24 times higher risk of CRN compared to those not on insulin. Contextual factors that significantly affected CRN included diabetes care factors, lifestyle factors, and comorbid depression, arthritis, and COPD/asthma. Dominance analysis showed health insurance was the most important factor for respondents <65 and depression was the most important factor for respondents ≥65.
Conclusions: In addition to traditional risk factors of CRN, compliance with annual recommendations for diabetes and healthy lifestyle were associated with lower CRN. Policies and social supports that address these contextual factors may help improve CRN.
Keywords: Diabetes; Income; Insurance; Lifestyle; Medication adherence.
Copyright © 2018 Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflict of Interest
The authors have no conflicts of interest to report.
Figures
Similar articles
-
Assessing the Importance of Factors Associated with Cost-Related Nonadherence to Medication for Older US Medicare Beneficiaries.Drugs Aging. 2019 Dec;36(12):1111-1121. doi: 10.1007/s40266-019-00715-3. Drugs Aging. 2019. PMID: 31686403
-
Cost-Related Medication Nonadherence in Adults With Diabetes in the United States: The National Health Interview Survey 2013-2018.Diabetes Care. 2022 Mar 1;45(3):594-603. doi: 10.2337/dc21-1757. Diabetes Care. 2022. PMID: 35015860
-
Cost-related nonadherence by medication type among Medicare Part D beneficiaries with diabetes.Med Care. 2013 Feb;51(2):193-8. doi: 10.1097/MLR.0b013e318270dc52. Med Care. 2013. PMID: 23032359 Free PMC article.
-
Attitudes, Beliefs, and Cost-Related Medication Nonadherence Among Adults Aged 65 or Older With Chronic Diseases.Prev Chronic Dis. 2018 Dec 6;15:E148. doi: 10.5888/pcd15.180190. Prev Chronic Dis. 2018. PMID: 30522585 Free PMC article.
-
Original Research: The Relationship Between Food Insecurity and Cost-Related Medication Nonadherence in Older Adults: A Systematic Review.Am J Nurs. 2020 Jun;120(6):24-36. doi: 10.1097/01.NAJ.0000668732.28490.c1. Am J Nurs. 2020. PMID: 32443122
Cited by
-
Racial and Ethnic Inequities in Diabetes Pharmacotherapy: Black and Hispanic Patients Are Less Likely to Receive SGLT2is and GLP1as.J Gen Intern Med. 2022 Oct;37(13):3501-3503. doi: 10.1007/s11606-022-07428-1. Epub 2022 Feb 9. J Gen Intern Med. 2022. PMID: 35141853 Free PMC article. No abstract available.
-
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024.Diabetes Care. 2024 Jan 1;47(Suppl 1):S158-S178. doi: 10.2337/dc24-S009. Diabetes Care. 2024. PMID: 38078590 Free PMC article. Review.
-
Diabetes Patients' Acceptance of Injectable Treatment, a Scientometric Analysis.Life (Basel). 2022 Dec 7;12(12):2055. doi: 10.3390/life12122055. Life (Basel). 2022. PMID: 36556420 Free PMC article. Review.
-
In the wake of a crisis: Caught between housing and healthcare.SSM Popul Health. 2023 Jun 13;23:101453. doi: 10.1016/j.ssmph.2023.101453. eCollection 2023 Sep. SSM Popul Health. 2023. PMID: 37456616 Free PMC article.
-
Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease.JAMA Netw Open. 2023 Jun 1;6(6):e2317886. doi: 10.1001/jamanetworkopen.2023.17886. JAMA Netw Open. 2023. PMID: 37307000 Free PMC article.
References
-
- Centers for Disease Control and Prevention. National diabetes statistics report, 2017; 2017.
-
- Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med 2015;32:725–37. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous